[Fatal outcome of invasive tracheal aspergillosis].
F
F
Scheer
F
F
Kuithan
P
P
Wiggermann
D000935:Antifungal Agents / Q000627:therapeutic use; D001980:Bronchi / Q000473:pathology; D002342:Carotid Artery, External / Q000473:pathology; D000077336:Caspofungin; D003287:Contrast Media / Q000008:administration & dosage; D054714:Echinocandins / Q000627:therapeutic use; D017809:Fatal Outcome; D006469:Hemoptysis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007472:Iohexol / Q000031:analogs & derivatives; D055666:Lipopeptides; D008297:Male; D009894:Opportunistic Infections / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000000981:diagnostic imaging; D055732:Pulmonary Aspergillosis / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000473:pathology; D011743:Pyrimidines / Q000627:therapeutic use; D036542:Tomography, Spiral Computed; D014132:Trachea / Q000000981:diagnostic imaging / Q000473:pathology; D014133:Tracheal Diseases / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole; D055815:Young Adult
D000935:Antifungal Agents; D003287:Contrast Media; D054714:Echinocandins; D055666:Lipopeptides; D011743:Pyrimidines; D014230:Triazoles; D007472:Iohexol; C038192:iopromide; D000077336:Caspofungin; D065819:Voriconazole